American International Group’s scPharmaceuticals SCPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-14,232
Closed -$71.4K 2236
2024
Q1
$71.4K Sell
14,232
-123
-0.9% -$689 ﹤0.01% 2680
2023
Q4
$90K Sell
14,355
-57
-0.4% -$326 ﹤0.01% 2615
2023
Q3
$103K Buy
14,412
+512
+4% +$4.03K ﹤0.01% 2501
2023
Q2
$142K Buy
+13,900
New +$145K ﹤0.01% 2363
2021
Q2
Sell
-4,079
Closed -$27K 3255
2021
Q1
$27K Buy
4,079
+11
+0.3% +$75 ﹤0.01% 3097
2020
Q4
$22K Sell
4,068
-118
-3% -$924 ﹤0.01% 3083
2020
Q3
$31K Buy
4,186
+899
+27% +$7.03K ﹤0.01% 2997
2020
Q2
$24K Buy
+3,287
New +$28.9K ﹤0.01% 3028
2019
Q2
Sell
-4,338
Closed -$13K 3148
2019
Q1
$13K Sell
4,338
-140
-3% -$481 ﹤0.01% 3025
2018
Q4
$17K Sell
4,478
-35
-0.8% -$164 ﹤0.01% 3037
2018
Q3
$26K Buy
4,513
+82
+2% +$417 ﹤0.01% 3120
2018
Q2
$25K Sell
4,431
-280
-6% -$2.88K ﹤0.01% 3039
2018
Q1
$58K Buy
+4,711
New +$63.3K ﹤0.01% 2866

Other funds holding SCPH

American International Group's SCPH Position: Q2 2024 in Review

American International Group sold out of scPharmaceuticals (SCPH) in Q2 2024, closing a stake of 14,232 shares — an estimated $71.4K sold.

American International Group first reported a position in SCPH in Q1 2018 and held it in 13 quarters. The position peaked at $142K in Q2 2023. 77 funds tracked by Wall St. Rank hold SCPH as of Q2 2024.

  • American International Group reported no remaining scPharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 14,232 scPharmaceuticals shares in Q2 2024, an estimated $71.4K.
  • American International Group first reported a position in scPharmaceuticals in Q1 2018 and held it in 13 quarters.
  • American International Group's scPharmaceuticals position peaked at $142K in Q2 2023.
  • 77 funds tracked by Wall St. Rank held scPharmaceuticals as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.